Synergistic effects of multiple natural products in pancreatic cancer cells

Life Sciences

Volumn 83, Issue 7-8, 2008, Pages 293-300

  Wang, Zhiwei ^a   Desmoulin, Sita ^a   Banerjee, Sanjeev ^a   Kong, Dejuan ^a   Li, Yiwei ^a   Deraniyagala, Rohan L ^a   Abbruzzese, James ^b   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Curcumin; Isoflavone; NF B; Notch 1

Indexed keywords

CURCUMIN; CYCLIN D; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOFLAVONE; NATURAL PRODUCT; NOTCH1 RECEPTOR; PROTEIN BCL 2; PROTEIN BCL XL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CHEMOPROPHYLAXIS; DNA BINDING; DRUG POTENTIATION; HUMAN; HUMAN CELL; INTRACELLULAR KILLING; PANCREAS CANCER; PROTEIN EXPRESSION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CELL LINE, TUMOR; CURCUMIN; DRUG EVALUATION; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; HUMANS; INCIDENCE; ISOFLAVONES; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION;

CURCUMA LONGA;

EID: 48549102229     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.06.017     Document Type: Article

References (33)

1. Banerjee S., Zhang Y., Ali S., Bhuiyan M., Wang Z., Chiao P.J., Philip P.A., Abbruzzese J., and Sarkar F.H. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Research 65 19 (2005) 9064-9072
2. Banerjee S., Zhang Y., Wang Z., Che M., Chiao P.J., Abbruzzese J.L., and Sarkar F.H. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. International Journal of Cancer 120 4 (2007) 906-917
3. El-Rayes B.F., Ali S., Ali I.F., Philip P.A., Abbruzzese J., and Sarkar F.H. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-κB. Cancer Research 66 21 (2006) 10553-10559
4. Fotsis T., Pepper M., Adlercreutz H., Hase T., Montesano R., and Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. Journal of Nutrition 125 3 Suppl (1995) 790S-797S
5. Goel A., Kunnumakkara A.B., and Aggarwal B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochemical Pharmacology 75 4 (2008) 787-809
6. Jang M.S., Miao H., Carlesso N., Shelly L., Zlobin A., Darack N., Qin J.Z., Nickoloff B.J., and Miele L. Notch-1 regulates cell death independently of differentiation in murine erythroleukemia cells through multiple apoptosis and cell cycle pathways. Journal of Cellular Physiology 199 3 (2004) 418-433
7. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M.J. Cancer statistics, 2008. CA Cancer Journal of Clinical 58 2 (2008) 71-96
8. Kotha A., Sekharam M., Cilenti L., Siddiquee K., Khaled A., Zervos A.S., Carter B., Turkson J., and Jove R. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Molecular Cancer Therapeutic 5 3 (2006) 621-629
9. Kunnumakkara A.B., Guha S., Krishnan S., Diagaradjane P., Gelovani J., and Aggarwal B.B. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products. Cancer Research 67 8 (2007) 3853-3861
10. Lev-Ari S., Starr A., Vexler A., Karaush V., Loew V., Greif J., Fenig E., Aderka D., and Ben-Yosef R. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Research 26 6B (2006) 4423-4430
11. Li Y., Ahmed F., Ali S., Philip P.A., Kucuk O., and Sarkar F.H. Inactivation of nuclear factor κB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Research 65 15 (2005) 6934-6942
12. Miele L. Notch signaling. Clinical Cancer Research 12 4 (2006) 1074-1079
13. Miele L., Miao H., and Nickoloff B.J. NOTCH signaling as a novel cancer therapeutic target. Current Cancer Drug Targets 6 4 (2006) 313-323
14. Miele L., and Osborne B. Arbiter of differentiation and death: notch signaling meets apoptosis. Journal of Cellular Physiology 181 3 (1999) 393-409
15. Miyamoto Y., Maitra A., Ghosh B., Zechner U., Argani P., Iacobuzio-Donahue C.A., Sriuranpong V., Iso T., Meszoely I.M., Wolfe M.S., Hruban R.H., Ball D.W., Schmid R.M., and Leach S.D. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3 6 (2003) 565-576
16. Nair P., Somasundaram K., and Krishna S. Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway. Journal of Virology 77 12 (2003) 7106-7112
17. Nair S., Hebbar V., Shen G., Gopalakrishnan A., Khor T.O., Yu S., Xu C., and Kong A.N. Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells. Pharmaceutical Research 25 2 (2008) 387-399
18. Oswald F., Liptay S., Adler G., and Schmid R.M. NF-κB2 is a putative target gene of activated Notch-1 via RBP-Jκ. Molecular and Cell Biology 18 4 (1998) 2077-2088
19. Plummer S.M., Holloway K.A., Manson M.M., Munks R.J., Kaptein A., Farrow S., and Howells L. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex. Oncogene 18 44 (1999) 6013-6020
20. Reddy S., Rishi A.K., Xu H., Levi E., Sarkar F.H., and Majumdar A.P. Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells. Nutrition and Cancer 55 2 (2006) 185-194
21. Sarkar F.H., and Li Y. NF-κB: a potential target for cancer chemoprevention and therapy. Frontiers in Bioscience 13 (2008) 2950-2959
22. Sarkar F.H., and Li Y. Soy isoflavones and cancer prevention. Cancer Investigation 21 5 (2003) 744-757
23. Sarkar F.H., and Li Y. Indole-3-carbinol and prostate cancer. Journal of Nutrition 134 12 Suppl (2004) 3493S-3498S
24. Sarkar F.H., and Li Y. Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Research 66 7 (2006) 3347-3350
25. Sethi G., Sung B., and Aggarwal B.B. Nuclear factor-κB activation: from bench to bedside. Experimental Biolology and Medicine (Maywood) 233 1 (2008) 21-31
26. Shankar S., Ganapathy S., Hingorani S.R., and Srivastava R.K. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Frontiers in Bioscience 13 (2008) 440-452
27. Shankar S., Suthakar G., and Srivastava R.K. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Frontiers in Bioscience 12 (2007) 5039-5051
28. Shen G., Khor T.O., Hu R., Yu S., Nair S., Ho C.T., Reddy B.S., Huang M.T., Newmark H.L., and Kong A.N. Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. Cancer Research 67 20 (2007) 9937-9944
29. Wang Y., Chan S.L., Miele L., Yao P.J., Mackes J., Ingram D.K., Mattson M.P., and Furukawa K. Involvement of Notch signaling in hippocampal synaptic plasticity. Proceedings of the National Academy of Sciences of the United States of America 101 25 (2004) 9458-9462
30. Wang Z., Banerjee S., Li Y., Rahman K.M., Zhang Y., and Sarkar F.H. Down-regulation of Notch-1 inhibits invasion by inactivation of nuclear factor-κB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Research 66 5 (2006) 2778-2784
31. Wang Z., Zhang Y., Banerjee S., Li Y., and Sarkar F.H. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 106 11 (2006) 2503-2513
32. Wang Z., Zhang Y., Banerjee S., Li Y., and Sarkar F.H. Inhibition of nuclear factor κb activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. International Journal of Cancer 118 8 (2006) 1930-1936
33. Wang Z., Zhang Y., Li Y., Banerjee S., Liao J., and Sarkar F.H. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Molecular Cancer Therapeutic 5 3 (2006) 483-493